A detailed history of Engineers Gate Manager LP transactions in Evolus, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 22,674 shares of EOLS stock, worth $370,493. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,674
Previous 15,786 43.63%
Holding current value
$370,493
Previous $221,000 11.31%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $71,979 - $94,778
6,888 Added 43.63%
22,674 $246,000
Q1 2024

May 15, 2024

SELL
$9.99 - $14.91 $152,387 - $227,437
-15,254 Reduced 49.14%
15,786 $221,000
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $51,003 - $70,666
6,711 Added 27.58%
31,040 $326,000
Q3 2023

Nov 14, 2023

SELL
$7.15 - $10.2 $182,546 - $260,416
-25,531 Reduced 51.21%
24,329 $222,000
Q2 2023

Aug 14, 2023

BUY
$7.23 - $10.52 $219,654 - $319,608
30,381 Added 155.97%
49,860 $362,000
Q1 2023

May 15, 2023

BUY
$7.81 - $11.05 $152,130 - $215,242
19,479 New
19,479 $164,000
Q2 2022

Aug 15, 2022

BUY
$10.22 - $13.94 $243,951 - $332,747
23,870 New
23,870 $277,000
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $132,875 - $299,859
-25,455 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $136,693 - $213,312
25,455 New
25,455 $166,000
Q3 2021

Nov 15, 2021

SELL
$7.36 - $13.67 $133,436 - $247,837
-18,130 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$8.42 - $13.96 $152,654 - $253,094
18,130 New
18,130 $229,000
Q1 2019

May 15, 2019

SELL
$12.43 - $28.91 $222,932 - $518,500
-17,935 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$10.57 - $19.29 $189,572 - $345,966
17,935 New
17,935 $213,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $917M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.